The US Food and Drug Administration (FDA) has approved a new drug for people who have been exposed to measles and hepatitis A viruses. This could be especially good news for older adults who are more likely to suffer from weakened immune systems and thus have more difficulty fighting off infections.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,